Austrian biotech Themis launches Zika vaccine clinical trial

(Reuters) - Austrian biotech company Themis Bioscience said on Tuesday it had started a clinical trial of an experimental Zika vaccine in healthy volunteers, opening up another front in the race to prevent the spread of the mosquito-borne disease.